Vimarsana
Biggest News Aggregation in the World

Page 4 - Cluster Headache News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cluster Headache. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cluster Headache Today - Breaking & Trending Today

iShowSpeed: What is iShowSpeed's 'deadly headache disease'? Know what happened to the YouTuber as he was rushed to the hospital - Vimarsana News

iShowSpeed: What is iShowSpeed's 'deadly headache disease'? Know what happened to the YouTuber as he was rushed to the hospital

​​iShowSpeed, a well-known internet personality and streamer, recently uploaded a worrisome video where he is seen hurriedly taken to the hospital due to what he describes as a "deadly headache."

World Brain Day: Waking Up To Headaches Can Be Worrying; Know Ways to Get Rid Of Them - Vimarsana News

World Brain Day: Waking Up To Headaches Can Be Worrying; Know Ways to Get Rid Of Them

Headaches are something all of us endure at some point in time. When ignored, sometimes they turn severe and can cause migraines, nausea and even vomiting. On the eve of World Brain Day, read on to what can cause headaches and a few ways to get over them. , Health News, Times Now

Cluster Headache | Histamine Headache: Types Causes Symptoms Treatment - Vimarsana News

Cluster Headache | Histamine Headache: Types Causes Symptoms Treatment

Cluster headache is a periodic, intense, sharp, burning and explosive pain that begins suddenly on one side of the head and tends to get worse quickly, reaching its peak within 10 minutes.

Headache Disorders Market Overview | Competitive Dashboard, Segment Analysis, Global Trend, Growth a - Vimarsana News

Headache Disorders Market Overview | Competitive Dashboard, Segment Analysis, Global Trend, Growth a

A worldwide Headache Disorders market research report offers an array of insights about Headache Disorders industry and business solutions that will support to stay ahead of the competition. A systematic investment analysis is also underlined in this report which forecasts impending opportunities for the market play...

FDA Expands Atogepant Approval to Include Chronic Migraine - Vimarsana News

FDA Expands Atogepant Approval to Include Chronic Migraine

The oral CGRP receptor antagonist atogepant is now approved to prevent migraine across frequencies, including episodic and chronic migraine.